EyePoint Pharmaceuticals Inc EYPT:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 06/29/22 EDT
7.83UNCH (UNCH)
Volume
7,851
Close
7.83quote price arrow up+0.01 (+0.13%)
Volume
89,449
52 week range
7.00 - 21.50
Loading...
  • Open7.85
  • Day High7.97
  • Day Low7.56
  • Prev Close7.83
  • 52 Week High21.50
  • 52 Week High Date11/15/21
  • 52 Week Low7.00
  • 52 Week Low Date06/13/22

Key Stats

  • Market Cap266.61M
  • Shares Out34.05M
  • 10 Day Average Volume0.16M
  • Dividend-
  • Dividend Yield-
  • Beta1.22
  • YTD % Change-36.03

KEY STATS

  • Open7.85
  • Day High7.97
  • Day Low7.56
  • Prev Close7.83
  • 52 Week High21.50
  • 52 Week High Date11/15/21
  • 52 Week Low7.00
  • 52 Week Low Date06/13/22
  • Market Cap266.61M
  • Shares Out34.05M
  • 10 Day Average Volume0.16M
  • Dividend-
  • Dividend Yield-
  • Beta1.22
  • YTD % Change-36.03

RATIOS/PROFITABILITY

  • EPS (TTM)-2.09
  • P/E (TTM)-3.76
  • Fwd P/E (NTM)-3.06
  • EBITDA (TTM)-59.846M
  • ROE (TTM)-47.51%
  • Revenue (TTM)38.91M
  • Gross Margin (TTM)77.99%
  • Net Margin (TTM)-172.48%
  • Debt To Equity (MRQ)23.81%

EVENTS

  • Earnings Date08/02/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On EyePoint Pharmaceuticals Inc

There is no recent news for this security.

Profile

MORE
Eyepoint Pharmaceuticals, Inc. is a pharmaceutical company. The Company’s lead product candidate, EYP-1901, combines a bioerodible formulation of its Durasert technology with vorolanib, a tyrosine kinase inhibitor (TKI), which has demonstrated anti-VEGF activity. The Company has two commercial products, YUTIQ and DEXYCU. YUTIQ is a non-erodible intravitreal implant containing fluocinolone acetonide (FA) lasting for up to 36 months and is indicated for the treatment of chronic...
Goran Ando M.D.
Non-Executive Independent Chairman of the Board
Nancy Lurker
President, Chief Executive Officer, Director
Jay Duker M.D.
Chief Operating Officer
George Elston
Chief Financial Officer
Address
480 Pleasant St Ste B300
Watertown, MA
02472-2468
United States

Top Peers

SYMBOLLASTCHG%CHG
OCUL
Ocular Therapeutix Inc
3.89+0.10+2.64%
RVLP
RVL Pharmaceuticals PLC
1.32+0.07+5.60%
HROW
Harrow Health Inc
7.03+0.01+0.14%
AZYO
Aziyo Biologics Inc
6.90+0.18+2.68%
ESPR
Esperion Therapeutics Inc
6.67+0.40+6.38%